NCT05147272
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05147272
Title Study of RP-6306 With Gemcitabine in Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Repare Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | CAN

Facility Status City State Zip Country Details
# 1018, Mayo Clinic Phoenix Arizona 85054 United States Details
# 1019, UCLA, Westwood Cancer Center Los Angeles California 90095 United States Details
# 1017, Mayo Clinic Jacksonville Florida 32224 United States Details
# 1022, Moffitt Cancer Center Tampa Florida 33612 United States Details
# 1023, START Midwest Grand Rapids Michigan 49546 United States Details
# 1016, Mayo Clinic Rochester Minnesota 55902 United States Details
# 1008, Columbia University New York New York 10032 United States Details
# 1004, Memorial Sloan Kettering Cancer Institute New York New York 10065 United States Details
# 1010, University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
# 2001, Princess Margaret Cancer Centre Toronto Ontario M5G 2C1 Canada Details
# 3003, Sarah Cannon Research Institute London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field